Insider Transactions in Q1 2024 at Beam Therapeutics Inc. (BEAM)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2024
|
Christine Bellon Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+20.3%
|
-
|
|
Mar 31
2024
|
Giuseppe Ciaramella President |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+16.73%
|
-
|
|
Mar 31
2024
|
Amy Simon Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+22.68%
|
-
|
|
Mar 31
2024
|
Terry Ann Burrell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+26.68%
|
-
|
|
Mar 31
2024
|
John M. Evans CEO |
BUY
Grant, award, or other acquisition
|
Direct |
77,500
+6.72%
|
-
|
|
Mar 28
2024
|
John M. Evans CEO |
SELL
Open market or private sale
|
Direct |
60,000
-5.67%
|
$1,980,000
$33.86 P/Share
|
|
Feb 14
2024
|
Fmr LLC |
SELL
Open market or private sale
|
Indirect |
900,000
-21.79%
|
$27,000,000
$30.93 P/Share
|
|
Feb 13
2024
|
Fmr LLC |
SELL
Open market or private sale
|
Indirect |
1,565
-0.03%
|
$46,950
$30.61 P/Share
|
|
Jan 31
2024
|
John M. Evans CEO |
SELL
Open market or private sale
|
Direct |
60,000
-5.37%
|
$1,500,000
$25.33 P/Share
|
|
Jan 03
2024
|
Christine Bellon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,907
-2.31%
|
$49,582
$26.42 P/Share
|